ECE 2024
Management of prolactinomas during pregnancy
www.high5endocrinology.tv | Meeting coverage | ECE 2024
ECE 2024
Management of prolactinomas during pregnancy
ECE 2024
Practice changing data on BRAF-inhibition in papillary…
ECE 2024
Recent studies that change my practice
ECE 2024
Is cavernous sinus surgery too dangerous?
ECE 2024
Sheehan syndrome: Still a challenge!
ECE 2024
The challenge of substituting cortisol after surgery in…
ECE 2024
AI-supported digital voice analysis in acromegaly
ECE 2024
Unnecessary MRI for mild hyperprolactinemia?
ECE 2024
Cushing’s syndrome: normalization of cortisol is just…
PaTHway
ECE 2024
Renal function with palopegteriparatide - data from the…
ARCH study
ECE 2024
Does sclerostin inhibition increase cardiovascular…
ECE 2024
Long-term data on kidney disease in hypopara-patients…
ECE 2024
Osteoporosis treatment with severely impaired kidney…
ECE 2024
Decision-making algorithm in hip fracture patients
ECE 2024
Bone turnover markers - is fracture prediction…
Epi-Hypo
ECE 2024
Hypoparathyroidism and renal calculus risk - unique…
ECE 2024
Vitamin D and K for bones and the vascular system?
ECE 2024
Molecular targeted precision medicine approach -…
ECE 2024
New therapeutic agents for postmenopausal hot flushes
ECE 2024
Εarly menopause: is it different from POi with respect…
ECE 2024
New treatment aspects of male fertility in AGS
ECE 2024
Management of cushing's syndrome during pregnancy
ECE 2024
Relevance of gluten-free diet in Hashimoto
ECE 2024
Update on the managment of Graves' disease
ECE 2024
Thyroid disorders during pregnancy - important take…
ECE 2024
HIF as a key factor in the development of…
Für den erfolgreichen Abschluss der Fortbildungsmodule ist die korrekte (mind. 70%) Beantwortung der Lernerfolgskontrolle für das jeweilige Modul verpflichtend.
Jetzt gleich den Fragebogen ausfüllen!